Helmuth van Es
Advisor, Strategic Corporate Development
Helmuth started his biotech career as a senior scientist at Crucell formerly IntroGene in Leiden, The Netherlands in 1994 and is a co-founder of Galapagos. At Galapagos he was Head of Science of the Leiden site of Galapagos until 2006. He co-developed the strategy of the company that moved from a functional genomics adenoviral RNAi technology platform to a biology driven, drug discovery and development company. In 2005 he founded BioConsilium which offers strategic, scientific and corporate expertise, a no-nonsense approach his network to companies, investors and academic research groups. From 2006 onwards he was CSO of Stem Cell Innovations Leiden until 2008. He is co-founder and director R & D of Audion Therapeutics a regenerative medicine, small molecule based company focusing on hearing loss based on intellectual property from the MEEI in Boston a Harvard Medical School affiliate. He is shareholder and non-executive board member of Antabio in Toulouse, a startup focussing on a new generation of antibacterials and serves on the board of Spinnovation Analytical. At ModiQuest he focusses on taking the organisation to the next level, by developing a strategy for its internal programs, optimising the organisation and attracting new partners and investors.